Cost & coverage estimator: will my plan cover this?

Ozempic and Wegovy are the same drug. Your insurer does not care.

Semaglutide is sold under two names. As Ozempic, it is approved and labelled for type 2 diabetes. As Wegovy, it is approved and labelled for weight. Tirzepatide does the same thing twice: Mounjaro for type 2 diabetes, Zepbound for weight. Inside each pair, the molecule is identical.

Insurers do not price molecules. They price indications. A plan that pays for Ozempic without blinking may exclude Wegovy from its formulary entirely — not deny it, exclude it, meaning the plan does not cover that category of drug for anyone, at any BMI, with any documentation. And that distinction is the most consequential thing you can learn before you start:

• A denial means the plan covers the category but says you have not met its criteria. It is a paperwork problem, and paperwork problems can be appealed — often successfully.
• An exclusion means your employer bought a plan that does not cover weight-management drugs. There is no criterion you can meet. Appealing it is a month of your life for nothing.

The pharmacy rejection message looks nearly identical either way. So the first call is not to your clinician. It is to your plan and, for an employer plan, to HR: does our plan exclude weight-management drugs?

If you are on Medicare or Medicaid, the coupon is not for you

Every “as little as $X a month” advert you have seen for a brand-name drug is aimed at people with commercial insurance. Manufacturer copay and savings cards generally cannot be used by people with Medicare or Medicaid. That is a rule of the federal programmes, not a decision your particular plan made, and there is no version of asking nicely that changes it.

Most people discover this at the pharmacy counter, with the drug on the other side of the glass. It is the most common and most demoralising surprise in this entire category, which is why this tool puts it in front of you the moment you say you are on Medicare or Medicaid rather than at the bottom of a page.

The levers that do exist for you are different, and they are bigger. On Medicare, Extra Help (the Low-Income Subsidy) lowers drug costs substantially for people under certain income and asset limits, and it is badly under-claimed because people assume they earn too much and never check. A formulary or tier exception is a real, defined process with real deadlines. On Medicaid, cost-sharing is capped at nominal amounts in the first place — the fight there is about authorization, not price.

Compounded “bioidentical” pellets: the one square with no coverage answer

Compounded hormone pellets and custom creams are essentially never covered, and the reason is structural rather than mean-spirited: they are not FDA-approved products. There is no approved label, so there is no formulary line, so there is nothing to appeal, no tier to except, and no manufacturer to issue a copay card. It is a cash purchase, and that is why it is sold as a cash package.

Two things are worth knowing before you buy one. “Bioidentical” does not mean “compounded.” FDA-approved estradiol and micronized progesterone are bioidentical — chemically identical to the hormones your body makes. They come with an approved label, a known dose, batch consistency, and a place on nearly every formulary. The marketing that sells pellets depends on you conflating those two words.

And a pellet cannot be removed once it is implanted. If the dose is too high, or you react badly, you wait it out — for months. A patch comes off in a second. A tablet stops the next morning. That asymmetry is not a coverage question, but it is the one that most deserves a moment before you sign anything. Read bioidentical hormone myths and bioidentical hormones before you commit.

The cheapest legitimate route to HRT

Generic estradiol — tablet or patch — plus generic micronized progesterone if you still have a uterus is usually the least expensive legitimate route to hormone therapy, and it sits on most formularies at a low tier. Both drugs have been off patent for decades. Branded gels, sprays and combination products are convenient, and you pay for that convenience; ask your clinician whether the generic form is clinically fine for you before you shop on price. See pills vs patches vs gels.

Levothyroxine is the exception that proves the rule. It is cheap and universally covered, but its therapeutic window is narrow, and switching between manufacturers to chase a lower price can move your TSH. Here, the money-saving move can be the wrong move: pick a product, stay on it, and if you ever do switch, ask for a TSH check six to eight weeks later.

A discount card is not insurance — and sometimes it still wins

A pharmacy discount card is a pre-negotiated cash price. It does not count toward your deductible or your out-of-pocket maximum, it does not make you covered, and you cannot stack it on a copay — you use the card or you use your insurance, one or the other.

But the honest version of that sentence has a second half, and almost nobody says it: for an old generic, the cash price with a card sometimes beats your copay outright, especially early in the plan year while you are still paying down a deductible. Ask the pharmacist to price it both ways and tell you which is lower. You are allowed to pay whichever one that is. We do not name a card, and we take no money from one.

Prior authorization is a documentation problem, not a wording trick

If a drug needs prior authorization, ask your plan for the written PA criteria. Then ask your clinician to submit the records that address those criteria point by point — diagnosis, what you have already tried and what happened, the relevant measurements and dates. Most PA denials are not refusals; they are incomplete submissions answered by a form.

Never misstate a diagnosis, a symptom or your history to get a drug covered, and never ask a clinician to. It is insurance fraud, it puts their licence on the line, and a false diagnosis does not evaporate — it lives in your medical record and reappears in every future coverage and underwriting decision you ever face. If your genuine history supports a covered indication, that is a clinical conversation with your clinician about facts that are already true. It is never a script.

If you are denied, appeal. Get the reason in writing, and ask for a letter of medical necessity that answers that exact reason. You have a right to an internal appeal and then to an independent external review — and most people never use either.

Where to take this next

For what menopause care costs across the board, start with how much menopause care costs and menopause treatment options compared. If you are weighing a telehealth route, how to choose online menopause care teaches you what to ask — we recommend no provider, and nobody pays to appear on this site's tools. If you want a clinician who does this properly, see how to find a menopause specialist. And on the GLP-1 side, GLP-1s explained and Ozempic alternativesare the places to go when the answer this tool gives you is “excluded.”